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Selective glutathione depletion on function and structure of the isolated
perfused rat kidney. The role of glutathione (GSH) in the preservation of
renal function and the pathogenesis of renal injury has been investigated
using the isolated perfused rat kidney as a model. In kidneys perfused
for 80 mm with 5 mi glucose as the only exogenous substrate, tissue
GSH becomes depleted, renal function deteriorates, and a degenerative
change appears, restricted to the medullary thick ascending limb. These
abnormalities can be ameliorated by providing amino acid supplements
or by adding GSH itself to the perfusion. To distinguish between the
effects of amino acid supplementation and GSH depletion per se,
selective depletion of GSH was accomplished in several different ways.
Synthesis of GSH was inhibited by the addition of dl-buthionine-SR-
sulfoximine, a specific inhibitor of gamma-glutamyl cysteine synthe-
tase. GSH depletion was also produced by 2-cyclohexene-l-one and
diethylmaleate, both known to diminish the concentration of GSH
selectively without affecting protein thiols. Perfused kidneys selectively
depleted of GSH showed significant impairment of concentrating abili-
ty, and less marked decreases in tubular reabsorption of sodium. The
degenerative changes in the medullary thick ascending limb, on the
other hand, were unaltered. While GSH depletion seriously impairs
certain renal transport functions, it is probably not responsible for the
anatomical disruption of the thick ascending limb that characterizes the
isolated perfused rat kidney.
Déplétion selective en glutathion sur Ia fonction et Ia structure du rein
de rat perfuse isolé. Le role du glutathion (GSH) sur Ia conservation de
Ia fonction rénale et La pathogenie des lesions rénales a été étudié en
utilisant un modéle de rein de rat perfuse isolé. Dans les reins perfusés
pendant 80 mm avec 5 mti glucose comme seul substrat exogéne, le
GSH tissulaire diminue, Ia fonction rdnale s'altère, et des modifications
dégéneratives apparaissent, limitées a l'anse ascendante large médul-
laire. Ces anomalies peuvent étre améliorées en apportant des supple-
ments en amino-acides, ou en ajoutant le GSH lui même a Ia perfusion.
Afin de distinguer entre les effets de Ia supplementation en acides
aminés et ceux de Ia déplétion en GSH elle méme, une déplétion
selective en GSH a été effectuée de plusieurs manières différentes. La
synthèse du GSH était inhibée par l'addition de dI-buthione-SR.sulfoxi-
mine, un inhibiteur spécifique de Ia gamma-glutamyl cysteine synthe-
tase. La depletion en GSH était egalement produite par le 2-cyclohex-
êne-l-one et le diethylmaleate, connus tous les deux pour diminuer
sélectivement Ia concentration de GSH sans affecter les thiols protein-
iques. Des reins perfuses sélectivement déplétés en GSH avaient une
diminution significative de Ia capacité de concentration, et des diminu-
tions moms marquees de Ia reabsorption tubulaire du sodium. Les
modifications degeneratives de l'anse ascendante large médullaire, par
ailleurs, étaient inchangées. Alors que Ia déplétion en GSH altére
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sérieusement certaines fonctions de transport renal, elle n'est probable-
ment pas responsable de l'interruption anatomique de l'anse ascendante
large qui caractérise le rein de rat perfuse isolé.
Glutathione (GSH) is thought to play a vital role in a number
of cellular reactions. Among its principal functions are the
maintenance of a stable redox state and the protection of cells
from oxidative injury caused by electrophilic compounds and
free radicals. The turnover of GSH is more rapid in the kidney
than in any other organ with a half-life of only 30 mm [1].
That GSH might have a special role in maintaining renal
function and structure was suggested by recent studies with the
isolated perfused rat kidney. When amino acids were omitted
from the perfusion medium, tissue levels of GSH fell rapidly
and a structural lesion developed that was localized to cells of
the thick ascending limb of Henle's loop (TAL). At the same
time, GFR and fractional sodium reabsorption (TRNa+) tended
to fall, and concentrating ability was severely impaired. The
addition of 20 physiological amino acids including cysteine to
the perfusate prevented GSH depletion, markedly attentuated
the anatomical damage to the TAL, and strikingly improved the
function and stability of the kidney [2]. Similar though less
marked improvement was seen when only the three amino acid
precursors of GSH, cysteine, glycine, and glutamic acid, were
added to glucose in the perfusion. These studies, however,
could not establish whether the functional and anatomlcal
defects observed in association with low levels of GSH in the
kidney were the specific consequences of GSH depletion or of a
more general amino acid deprivation. The present experiments
were therefore designed to modify the renal content of GSH in a
variety of ways and to study the effects of these manuevers on
renal function and structure.
Methods
Kidney perfusion. Male Sprague-Dawley rats, weighing 330
to 500 g, were used for all experiments. The rats were fed rat
chow (Purina) and allowed free access to water. The animals
were anesthetized intraperitoneally with mactin®, 100 mg/kg.
Perfusion of the right kidney was performed as described by
Ross, Epstein, and Leaf [3]. Perfusion pressure was maintained
at 85 mm Hg at the tip of the cannula. The standard perfusion
medium was Krebs-Henseleit physiological saline, gassed with
95% 02/5% CO2 containing 5 m glucose and 6.7 g% bovine
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serum albumin, Fraction V (Miles Laboratories, Elkhart, Indi-
ana). A control group of kidneys (group 1, N = 10) was perfused
with this basic medium, which rapidly depleted the kidney of
GSH, as previously reported [2]. The following supplements
were added to modify tissue levels of GSH in the perfused
kidney.
GSH repletion. Repletion of tissue GSH was obtained in two
ways: (1) Amino acid supplementation (group 2, N = 10): all 20
physiological L-amino acids were added to the medium at
concentrations between two- and threefold higher than their
normal concentration in rat plasma, except for cysteine added
at 0.5 m, as described by Epstein et al [2]. Lysine, tyrosine,
cysteine, aspartic acid, glutamic acid, asparagine, glutamine,
and saline were weighed, and added to the medium (13.3, 2.17,
7.85, 2.66, 7.35, 2.64, 29.2, and 10.51 mg, respectively for 1 dl of
medium). One milliliter of 8.5% Travasol® (Travenol Labora-
tories, Morton Grove, Illinois) per 100 ml of medium was used
as a convenient source of the rest of the amino acids. (2) GSH
supplementation (group 3, N = 8): GSH (Sigma Chemical Co.,
St. Louis, Missouri) was added to the perfusion medium just
prior to cannulation of the kidney to a final concentration of 2 to
3 mM.
GSH depletion. Using the same amino acid supplementation
as in group 2, the following agents were added to produce
selective GSH depletion in the presence of the amino acids: (1)
Buthionine sulfoximine (BSO) (group 4, N = 10): dI-buthionine-
SR-sulfoximine (Chemical Dynamics Co., South Plainfield,
New Jersey), a potent and specific inhibitor of gamma-gluta-
myl-cysteine synthetase [4] was added to a concentration of 0.5
to 1 mM. In a subgroup, an attempt was made to potentiate the
effect of BSO by omitting cysteine. Because the results (GSH
content, function, and histology), with or without cysteine,
were identical, the data were pooled in one group. (2) 2-
Cyclohexene-1-one (CHX) (group 5, N 8): CHX (Aldrich
Chemical Co., Milwaukee, Wisconsin), a selective GSH deplet-
ing agent [5], was added to a concentration of 0.8 ms'i. As
control, cyclohexanone (Sigma Chemical Co., St. Louis, Mis-
souri), an inactive analogue of CHX, was tested at the same
concentration (N = 3). (3) Diethylmaleate (DEM) (group 6, N =
8): DEM (ICN Pharmaceuticals, Plainview, New York), anoth-
er selective GSH depleting agent [6], was added to a concentra-
tion of 1.0 to 1.4 mM.
Assessment of renal function. GFR was taken as the clear-
ance of 3H-inulin (New England Nuclear Corporation, Boston,
Massachusetts); sodium and potassium were measured by
flame photometry. The ability of the perfused kidney to elabo-
rate a concentrated urine sample was tested as follows:
Des-amino,8 ,arginine vasopressin (DDAVP, Ferring Pharma-
ceuticals, New York, New York) was added to the recirculating
perfusion medium at the start of the experiment to a concentra-
tion of 1 ng/ml, and this dose was repeated after 30 mm of
perfusion. Urea was added to a concentration of 10 m. This
was repeated after 30 mm. After 20 mm of equilibration, urine
samples were collected every 10 to 20 mm for 70 mm, and a
sample of perfusate was obtained from the venous reservoir at
the midpoint of each urine collection period.
Osmolarity of urine and perfusate were measured by freezing
point depression (Advanced Digimatic® Osmometer, Advanced
Instruments).
Morphologic techniques. Kidneys were fixed after 90 mm of
perfusion. A three-way stopcock was incorporated into the
circuit 5 cm from the arterial cannula to allow perfusion with the
fixative solution at the same pressure as during the measure-
ment of renal function for an additional 5 to 8 mm. The fixative
solution contained 1.25% of glutaraldehyde in 0.1 M phosphate
buffer at pH 7.4. A 2-mm section of the outer medulla was
removed, postfixed in 2% 0504, dehydrated, and embedded in
an araldite-epon 812 mixture. Sections (1 .t)were cut to include
the entire length of the medullary thick ascending limb (TAL).
Selected blocks were examined by electron microscopy.
All histological evaluations were completed by a renal pathol-
ogist in a "blinded" fashion; that is, without prior knowledge of
the way the perfused kidneys had been treated.
As previously described and confirmed in detail by our
observations [9], the epithelium of the TAL undergoes a
selective degenerative change, beginning with chromatin mar-
gination and luminal membrane blebbing, progressing with the
addition of marked mitochondrial swelling, and ending with
nuclear pyknosis and cell fragmentation. Although there is
variation, both type and extent (number of limbs affected) of
such alterations proportionally increase with time of perfusion.
The following are the scoring methods which were applied to
the l- sections:
• 0 = no demonstrable lesion
• 1 = chromatin margination, minor degrees of mitochondrial
swelling
• 2 = blatant mitochondrial swelling with limited nuclear
pyknotic changes
• 3 = blatant mitochondrial swelling with extensive nuclear
pyknotic change and cell fragmentation, but approximately
less than one-half the nephron population involved
• 4 = as 3 but over one-half the nephron population involved.
Scoring was done in three zones: upper one-third (adjacent to
outer strip), middle third, and lower third (adjacent to inner
medulla).
Measurement of tissue GSH. After 60 mm of perfusion,
kidneys were weighed rapidly and homogenized, using a Tek-
mar homogenizer. The solution used for homogenization con-
sisted of phosphate-EDTA buffer and 25% phosphoric acid.
After centrifugation at 4°C at X lOO,000g for 30 mm, the
supernatant was assayed for reduced GSH using the fluoromet-
ric method described by Hissin and Hilf [6]. The results are
expressed in micromolar concentrations per gram dry weight
and are comparable to the results obtained on quick-frozen
tissue [2].
The data are presented as mean SEM. Statistical analysis
was by Student's t test, A P value of less than 0.05 was taken to
represent a significant difference.
Results
Perfusion with glucose alone (Table 1). In the control group
(group 1) perfused with glucose as the only substrate, renal
function deteriorated progressively in the course of perfusion.
The decline in sodium and potassium reabsorption and the
inability to concentrate urine were similar to results reported
earlier [2, 7—9]. A histological lesion confined to the TAL was
identified and characterized by mitochondrial swelling, progres-
sive nuclear pyknosis, and cell fragmentation to cell death, as
described by Alcorn et al [91. Tissue GSH was depleted by
glucose perfusion, the renal content of GSH falling to 60% of
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Table 1. Effects on kidney function and structure of perfusing with glucose alone and of supplementing with amino acids or GSH
GFR
mi/mm
TRNa+
%
FeK
% U/Posm
Scoring of TAL
proximal lesion
Duration of perfusion,
mm 20 to 30 70 to 80 20 to 30 70 to 80 20 to 30 70 to 80 70 to 80
Controls (N = 10) 5 mM
glucose 0.67 0.05 0.51 0.06 97.6 0.5 94.8 1.5 25.0 2.9 57.2 12.5 1.30 0.03 3.1 0.15
Glucose plus amino acid
supplementation(N = 10) 0.83 0.07 0.86 O.O5c 99.5 0.09b 99.2 0.18" 8.9 2.2c 11.5 2.4a 1.58 0.03c 1.9 0.19c
Glucose plus GSH
supplementation(N = 8) 0.79 0.09 0.75 0.07a 98.1 0.5 98.1 Ø4a 30.7 9.1 36.9 3.6 1.51 0.04" 2.4 0.12"
Significance vs. controls:
a P < 0.05.
"P < 0.01.
P < 0.001.
C M
M/C
(%)
Normal (N = 3) 4.87 0.03 3.03 0.24 63 5
Perfused with glucose
(N = 4) 3.8a 0.35 l.97a 0.26 50 4
Perfused with amino acids
(N = 3) 6.39 0.48 2.94 0.27 43 8
Perfused with amino acids
and CHX (N = 3) 2.44" 0.13 1.07a 0.26 42 9
Perfused with amino acids
and DEM (N = 2) 3.61 1.26 35
Perfused with amino acids
and BSO (N = 1) 3.65 1.57 43
normal after 60 mm. GSH content of both cortex and red
medulla were depleted by glucose perfusion (Table 2).
Prevention of GSH repletion by perfusing with amino acids
or GSH. As shown in Figure 1, a fall in kidney GSH was
prevented in groups 2 and 3 by the addition of amino acids or
GSH to the perfusion.
Amino acid supplementation produced a striking improve-
ment in the function and the stability of the preparation. GFR
remained at its initial level for the duration of the perfusion,
fractional reabsorption of sodium was sustained at about 99%,
and the fractional excretion of potassium was reduced to the
range (6 to 12%) found in vivo. Concentrating ability was
considerably improved in the presence of amino acids, with a
ratio of urine to perlusate osmolality (U/P)osm of 1.6, as
compared to 1.3 to 1.4 in kidneys perfused with glucose as the
only substrate (Fig. 2). The histological appearance of the TAL
was improved significantly by the addition of amino acids. Only
the early lesion of mitochondrial swelling was present, nuclear
.c
.'
.
i
Normal Glu AA GSH
(N=5) (N=5) (N=7) (N=5)
Fig. 1. Renal GSH content during perfusion with glucose (Glu), with
amino acids (AA), or with exogenous GSH. The asterisk refers to P <
0.001 versus each of the other columns.
pyknosis was uncommon, and cytoplasmic disruption rare. In
all three portions of the TAL, scoring of the damage was
substantially lower in kidneys perfused with the amino acids
than in the group perfused with glucose alone (Fig. 3). These
results confirm those reported earlier [2].
Addition of GSH to the medium also produced an improve-
ment in concentrating ability resembling that obtained with
amino acids (Fig. 4). Improvement in the stability of the
preparation, as reflected in GFR, reabsorption of Na+ and K+,
and histology of the TAL, were also noted but they were not so
marked as with the addition of the 20 amino acids.
Effects ofGSH depletion (Table 3). The addition to an amino
acid perfusion of buthionine sulfoximine (BSO) or diethylma-
leate (DEM) caused moderate GSH depletion to a level of 3.6
Table 2. GSH tissue levels in cortex (C) and outer medulla (M)a 8
7
6
5
4
3
2
0
7 /
/
4a Values are mena SE (/2M/g dry weight).
aP < 0.05 (vs. normal).b p < 0.01 (vs. amino acids).
//
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1.5 — U0,,, at 80' (mOsmlkg H20)
Control 365± 11 P<0.001AA 465± 6
L I
20 30 40 50 60 70 80
Time, minutes
Fig. 2. Effect of the addition of2O amino acids to the perfusion medium
on concentrating ability of the isolated perfused kidney. Controls are
perfused with glucose as the only substrate. Symbols are: •, amino
acids (N = 10); 0, controls (N = 10); *, P < 0.001.
Fig. 3. Scoring of mitochondrial and nuclear damage of TAL in kidneys
perfused with glucose (Glu) and with amino acids (AA). Abbreviations
and symbols are: D, distal; TAL, near pars recta; M, middle TAL; P,
proximal TAL, near thin limb; *, P <0.05; * P < 0.001.
0.21 and 3.3 0.11, respectively. 2-Cyclohexene-1-one (CHX)
produced more severe GSH depletion, that is, to 2.3 0.03.
Both cortex and medulla participated in the depletion (Table 2).
The influence of GSH-depleting agents on GFR, sodium, and
potassium excretion are summarized in Table 3. There was no
significant effect on GFR. Both CHX and DEM produced small
but significant reductions in sodium reabsorption. The excre-
tion of potassium was increased only in the group treated with
DEM.
More striking consequences of specific GSH depletion were
observed in renal concentrating ability (Fig. 5). Both BSO and
DEM abolished the beneficial effect of amino acid supplementa-
I I
20 30 40 50 60 70 80
Time, minutes
Fig. 4. Effect of the addition of GSH to perfusion medium on concen-
trating ability of the isolated perfused kidney. Symbols are: •, GSH (N
= 8); 0, control (N = 10); ", P < 0.05; **, P < 0.02; P < 0.01.
I I I
20 30 40 50 60 70 80 90
Time, minutes
Fig. 5. Effect of chemical depletion of renal GSH with BSO, CHX, and
DEM on concentrating ability in kidneys perfused with amino acids.
Values shown are mean SEM. Symbols are: ', P <0.01; **, P <0.05;
+, P < 0.001; ++, P < 0.005.
tion on (U/P)osm, reducing this ratio to 1.2 1.32. CHX, the
most potent GSH-depleting agent, caused a further reduction in
(UIP)osm, lowering it to 1.2 0.04.
Cyclohexanone, a biochemically inactive analogue of CHX
1.7 1.6
1.6
*
* E
a.
1.4
1.3
1.5
1.4
1.3
1.2
GLU (N=7)
+4
+3
Max U0, mOsm/kg H20
AA 479±15
BSO 426±9
CHX 376±10
DEM 422±12
AA vs. BSO P<0.01
AA vs. CHX P<0.001
AA vs. DEM P<0.02
AA (N=7)
4
0 M PD M P
1.7
1.6
1.5
S
1.4
1.3
1.2
1.1
AA
(N=10)
BSO(N10)
DEM
IN=8)
CHX
(N=8)
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Table 3. Effects of GSH depletion on renal function during perfusion with amino acids
GFR
mi/mm
-______________
TRNa
%
FEK.
% u/P0,,,
70 to 80 mm
GSH
M/g dry wt20 to 30 mm 70 to 80 mm 20 to 30 mm 70 to 80 mm 20 to 30 mm 70 to 80 mm
Amino acid
supplementation
(N = 10) 0.83 0.07 0.86 0.05 99.5 0.09 99.2 0.18 8.9 2.2 11.5 2.4 1.58 0.03 6.5 0.45(N =7)
BSO
(N = 10) 0.92 0.05 0.78 0.06 99.3 0.24 98.4 0.28 13.8 2.3 19.3 3.1 1.40 0.02c 3.6 0.21c(N =5)
CHX
(N = 8) 0.67 0.08 0.67 0.11 97.7 0.58a 94.6 l.43 12.0 1.5 17.1 1.9 1.20 0.04 2.3 0.03c(N = 4)
DEM
(N = 8) 0.86 0.03 0.83 0.07 98.8 0.38 95.2 0.89 21.2 2.6b 30.0 39b 1.32 0.06k' 33 0.11(N = 4)
AA BSO OEM CHX(N7) (N=4) (N=4) (N=5)
Fig. 6. Scoring of mitochondrial and nuclear
damage during GSH depletion. Abbreviations
and symbols are: D, distal TAL (near pars
recta); M, middle TAL; P. proximal TAL
(near thin limb); *, P < 0.05 (vs. AA).
[5] did not lower kidney GSH content (6.35 pM/g dry weight, N
= 2) and produced no detectable deterioration in kidney func-
tion: GFR, 0.78 0.15 mi/mm; FRNa+, 98.9 0.45%; U/Posm,
1.54 0.09 (N = 3); these values are not significantly different
from those of group 2.
Unexpectedly, structural damage to thick ascending limb
cells was not increased by specific GSH depletion (Fig. 6). With
BSO and DEM there was a slight increase in the scoring of
damage in cells of the distal thick ascending limb, whereas CHX
appeared to produce a small improvement in the damage in the
middle portion of the thick limb (Fig. 7).
Discussion
The maintenance of adequate levels of reduced GSH is
thought to be necessary in animal cells to protect against
oxidative damage to membrane proteins and lipids and to
intracellular enzymes, resulting from the formation of hydrogen
peroxide, superoxide, and other free radicals [101. Although it is
well known that membrane permeability in other systems (for
example, red blood cells [11], cornealepithelium [12]) is greatly
altered by changes in the redox state of GSH, the role of GSH in
the kidney has not been extensively explored. The present
study was undertaken to examine the role that GSH plays in
preserving normal renal function and structure.
In confirmation of earlier observations [2], we found that
when isolated rat kidneys were perfused with glucose as the
only substrate, a fall in tissue levels of GSH was noted,
accompanied by deterioration of renal function and the appear-
ance of anatomical lesions in cells of the medullary thick
ascending limb. Repletion of GSH with a full complement of
amino acids or by direct supplementation of the perfusion
medium with GSH was consistently associated with improve-
ment in function and structure. The improvement in concentrat-
ing ability was particularly striking in view of the increase in the
rate of flow of perfusate to the kidney that accompanied the
addition of amino acids or GSH. A higher rate of perfusion
might be expected to aggravate medullary washout, believed to
play a major role in the concentrating defect of perfused
kidneys [8]. It is likely that the GSH added to the recirculating
Abbreviations: BSO, buthionine sulfoximine; CHX, 2.cyclohexene-1-one; DEM, diethyl maleate.
Significance vs. amino acid supplementation alone: P < 0.05; b P < 0.01; P < 0.001.
+4
+31-
+1
D M P 0 M P DM P DM P
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Fig. 7. After 90 mm of perfusion (A) with 5 m glucose, thick ascending limbs of Henle (bar) show nuclear pyknosis and extensive cell
fragmentation. If amino acids are added to the perfusate (B), the structural integrity of the cells are better maintained but marked mitochondrial
swelling is evident. Addition of BSO and amino acids to the perfusate (C) reduces glutathione tissue levels but only slightly reduces the improved
cellular integrity relative to the amino acid addition. Although very low tissue levels are produced by cyclohexane, when the substance was added
to the perfusate containing amino acids (D), not only was the improvement relative to the amino acids maintained, but mitochondrial swelling was
significantly reduced as well. (i-p. plastic sections, methylene-bolus-aznre 11-basic fuschia, x315.)
medium is rapidly hydrolyzed to its constituent amino acids and
subsequently resynthesized inside renal cells 13, 14J. The fact
that improvement occurred with GSH supplementation alone
does not, therefore, eliminate the possibility that the provision
of amino acids per se (rather than specific repletion of GSH)
might play the key role in ameliorating the structural or
functional defects that develop with glucose perfusion. Further
experiments were therefore designed to produce selective de-
pletion of GSH in the presence of a full complement of 20 amino
acids.
Specific GSH depletion, induced either by inhibition of
biosynthesis with BSO, or by chemical alkylation with CHX or
DEM, abolished the beneficial effects of amino acids on con-
centrating ability, and in the case of CHX, depressed (U/P)osm
even below the levels achieved during perfusion with glucose
alone. It seems unlikely that this resulted from nonspecific toxic
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actions of these drugs unrelated to their effects on GSH. In the
concentrations used here, BSO is a highly selective inhibitor of
gamma-glutamyl synthetase without any established inhibitory
action on other enzymes, such as, for example, glutamine
synthetase [4]. Both CHX and DEM are known to produce
selective depletion of GSH in isolated cells, without affecting
oxidized GSH or protein thiols [5].CHX at concentrations up to
10 m does not alter basal or ADH-mediated water flow in toad
bladder (J. S. Stoff, unpublished observations). Furthermore, a
chemical analogue of CHX that lacked the ability to produce
GSH depletion did not impair concentrating ability. The corre-
lation between the severity of GSH depletion and the degree of
impairment in concentrating ability produced by various ma-
neuvers also strengthens the notion of a cause-and-effect rela-
tionship between the two. Both cortex and medulla appeared to
participate equally in the GSH depletion produced by
cyclohexanone.
The site and mechanism of this effect of GSH on concentrat-
ing ability remains unclear, but it appears to be separable from
the mitochondrial disruption in the thick ascending limb that
occurs when amino acids are eliminated from the perfusate.
While repletion of GSH levels with amino acids (or GSH alone)
diminished histological damage at the same time that concen-
trating ability was restored, chemical depletion of GSH in renal
tissue did not exacerbate the anatomical lesion although con-
centrating power was impaired. It is conceivable that the
development of the mitochondrial lesion is related to the burden
of transport work in TAL cells and that chemical depletion of
GSH might inhibit transport in these cells through an action on
extramitochondrial structures, thereby reducing mitochondrial
work and avoiding mitochondrial damage. It is noteworthy that
diamide, a potent but less specific GSH oxidant, markedly
reduces Na-K-ATPase activity in kidney slices [5].
These results that suggest a role for GSH in normal kidney
function may be relevant to clinical examples of nephrotoxicity
associated with depletion of renal GSH. Acetaminophen and
phenacetin overdosage deplete tissue GSH reserves and this
may be true of other analgesics as well [16]. GSH depletion has
therefore been invoked in the pathogenesis of chronic analgesic
nephropathy [17]. Renal GSH may also be involved in protect-
ing against the interstitial nephritis caused by radiomimetic
agents which act by increasing the formation of free radicals in
cells [18]. Mild GSH and amino acid depletion associated with
protein malnutrition might conceivably contribute to the defect
in renal concentrating ability that accompanies this condition
[19]. Finally, the special sensitivity of the concentrating func-
tion of the perfused kidney to GSH depletion is of particular
interest since it suggests the possibility of GSH involvement in
certain clinical disorders of the ability of the kidneys to concen-
trate urine.
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